Business Standard

Fortis Health up 4% as unit buys S'pore firm

Image

SI Reporter Mumbai

Fortis Healthcare (India) is trading higher by 4% at Rs 108 after the company said that it has acquired 85% stake in Redline-Asia Pvt Ltd, an outpatient diagnostic and molecular imaging chain in Singapore, for Singapore $62.9 million. The acquisition has been routed through Singapore subsidiary.

“The transaction provides Fortis Healthcare a strong foothold in the premium diagnostics and molecular imaging segment in one of Southeast Asia's most attractive markets besides providing a complementary platform to its upcoming specialty hospital on Adam Road in Singapore,” the company said in a filing to the stock exchanges.

Redline has four main business segments; diagnostic imaging, molecular imaging, cyclotron (radio-isotopes manufacturing) and GP clinics, it added.

 

A combined 60,000 shares have changed hands on the counter so far on the NSE and BSE.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 01 2012 | 9:47 AM IST

Explore News